Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ⅱ Study of Erythropoietin for Management of Anemia Caused by Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

NCT02890602 is registered in ClinicalTrials.gov with Kosin University Gospel Hospital as lead sponsor.

NCT NCT02890602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02890602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ⅱ Study of Erythropoietin for Management of Anemia Caused by Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
Lead sponsor
Kosin University Gospel Hospital
Phase
Phase 2
Overall status
Completed
Start date
September 1, 2012
Completion date
December 7, 2017
Enrollment
53 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b-cell lymphoma